In This Section

Global Scholar-in-Training Awards Recipients

The AACR is proud to offer 14 Global Scholar-in-Training Awards (GSITA) to meritorious early-career scientists from countries building cancer research capacities at AACR’s 2021 Annual Meeting. The GSITA program builds upon the success of the African Cancer Research Travel Award, which over three years (2016-2018) benefited 15 African scientists from seven countries—Egypt, Ghana, Morocco, Nigeria, Senegal, South Africa, and Sudan—and expands the program to eligible investigators from countries building cancer research capacities. In 2021, the awardee class represents nine countries– Argentina, Brazil, China, Egypt, India, Malaysia, Mexico, Nigeria, and South Africa.

Isaacson Bababode Adelani

Isaacson Bababode Adelani

Covenant University
Ota, Nigeria

Abstract 2529: Specific racial CYP2R1 correlation with circadian rhythm genes in prostate adenocarcinoma

Adeleye Adeshakin

Adeleye Adeshakin

Shenzhen Institute of Advanced Technology
Shenzhen, China

Abstract 1901: Diglyceride acyltransferase 1 reprograms lipid metabolism in myeloid-derived suppressor cells and augments immune checkpoints cancer immunotherapy

AJAYI BABAJIDE OLUWASEUN, PhD

AJAYI BABAJIDE OLUWASEUN, PhD

Ajayi Crowther University
Oyo, Nigeria

Abstract 2842: 6-gingerol attenuates metastasis in aged mice model of colorectal cancer through modulation of epithelial-mesenchymal transition mediators genes and e-cadherin upregulation

Juan Bizzotto

Juan Bizzotto

Universidad de Buenos Aires
Buenos Aires, Argentina

Abstract 710: Androgen-deprivation therapy boosts MX1 expression, a silent effector against COVID-19

Annie Wai Yeeng Chai, PhD

Annie Wai Yeeng Chai, PhD

Cancer Research Malaysia
Kuala Lumpur, Malaysia

Abstract 1226: Targeting OSCC fitness genes YAP1 and WWTR1 via synergistic killing of CA3 in combination with cisplatin

Kezhong Chen, MD

Kezhong Chen, MD

Peking University People’s Hospital
Beijing, China

Abstract 618: Spatio-temporal multiomics analysis reveals distinct molecular features in recurrent stage I non-small cell lung cancers after R0 tumor resection

Leticia Ferro Leal, PhD

Leticia Ferro Leal, PhD

Molecular Oncology Research Center, Barretos Cancer Hospital
Barretos, Brazil

Abstract 2165: Reproducibility of a 12-gene panel and development of user-friendly nomogram-based calculator for clinical management of surgically resected non-small cell lung cancer patients

Mariam Fouad, PhD

Mariam Fouad, PhD

National Cancer Institute, Cairo University
Cairo, Egypt

Abstract 990: Differential immunoregulatory effects of decitabine on lipid metabolism in doxurobicin versus tamoxifen treated breast cancer cells

ALIN GARCIA MIRANDA

ALIN GARCIA MIRANDA

Autonomous University of Guerrero – CIBIOR, IMSS
Guerrero, México

Abstract 1940: Autophagy mediates leptin induced migration and erk activation in breast cancer cells

Rahaba Makgotso Marima, PhD

Rahaba Makgotso Marima, PhD

University of Pretoria
Gauteng Province, South Africa

Abstract 2156: Genomics and molecular analysis of Aurora kinase B (AURKB) in response to antiretroviral (ARV) treatment in lung cancer

Carla Daniela Robles-Espinoza, PhD

Carla Daniela Robles-Espinoza, PhD

International Laboratory for Human Genome Research (LIIGH), National Autonomous University of Mexico (UNAM)
Queretaro, QRO, Mexico

Abstract 2222: The molecular landscape of acral lentiginous melanoma in Mexican patients

Alka Singh, PhD

Alka Singh, PhD

Motilal Nehru National Institute of Technology Allahabad
Prayagraj, India

Abstract 480: Aberrant promoter hypermethylation of HIC1 and SOX1 in circulating cell free DNA as a potential biomarker for noninvasive early detection of ovarian cancer

Marcela Teatin Latancia

Marcela Teatin Latancia

Institute of Biomedical Sciences, University of São Paulo
São Paulo, Brazil

Abstract 1178: Role of error-prone polymerases on glioma cell resistance to Temozolomide

Apoorva Uboveja

Apoorva Uboveja

Dr.B.R.Ambedkar Centre for Biomedical Research, University of Delhi
New Delhi, India

Abstract 2388: p73 – lncRNA FER1L4 axis plays a critical role in suppression of cancer cell migration, invasion and metastasis in a p73-dependent manner via inhibition of miR-1273g-3p